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It is widely known that a carcinoid tumor can produce varioushormones and is sometimes detected on the basis of thepresence of various symptoms caused by the hormones.Cushing syndrome is widely known as one of these symp-
toms. Many cases of Cushing syndrome have been reported, but
occasionally, it is very difficult to detect a tumor that produces
adrenocorticotrophic hormone (ACTH).1,2 We herein report a rare
case of a carcinoid tumor that metastasized to a lymph node,
resulting in production of ACTH. Although the lymph node was
not enlarged by tumor metastasis, we were able to localize the
lymph nodes as the origin of ectopic ACTH production by means
of 111In-octreotide scanning. The lymph nodes were completely
resected with thoracoscopic surgery, and the symptoms success-
fully disappeared after the operation.
Clinical Summary
The patient was a 55-year-old woman who had had hypertension
since 1991. However, she refused any treatments. In 1996, she
reported having facial edema. Hypertension and hypokalemia were
detected during examination. Both plasma ACTH and serum cor-
tisol levels were increased (ACTH, 121 pg/mL [normal range,
4.4-48.0 pg/mL]; cortisol, 26.6 g/dL [normal range, 1.39-24.20
g/dL]). Increased 17-hydroxycorticosteroids and 17-ketosteroids
in the urine were also noted. She was given a diagnosis of Cushing
syndrome. Brain magnetic resonance imaging and abdominal com-
puted tomography (CT) failed to detect any tumor mass. The
administration of an oral antihypertensive agent was started, and
the serum cortisol level decreased to the normal value, although
the plasma ACTH level was still increased (95.4 pg/mL). Whole-
body screening was performed, and an abnormal mass was de-
tected by means of chest CT in February 1996 (Figure 1, A),
suggesting lymphadenopathy in the anterior mediastinum. No
change in tumor size was seen with serial examination until 2001.
Thus, we were not able to obtain proof that this mediastinal mass
was the origin of ectopic ACTH secretion. In 2001, an 111In-
octreotide scan was performed, which showed a hot spot in the
right upper mediastinum (Figure 1, B).3 The ACTH value in the
superior vena cava4 was also shown to be higher than that in the
peripheral veins. All these findings strongly suggested that the
mediastinal mass was an ACTH-producing tumor.
The patient underwent tumor resection with a thoracoscope on
May 18, 2001. The tumor seemed to be a solitary, enlarged lymph
node, and no other tumor was detected in either the right lung or
the mediastinum by means of thoracoscopy. Pathologic examina-
tion showed the tumor to be a pair of metastatic lymph nodes (No.
3 [1/6] and No. 4 [4/15]) involved with an atypical carcinoid tumor
(Figure 2). Immunohistochemical staining results for ACTH was
positive. Examination with a fiberoptic scope targeting the gastro-
intestinal region, the colon, and the bronchi after the operation
failed to find the primary region of the tumor. Plasma ACTH and
serum cortisol values decreased to normal levels after the opera-
tion.
Discussion
Cushing syndrome related to ectopic ACTH production is associ-
ated with a variety of solid tumors (ie, lung cancer, bronchial
carcinoid, thymic carcinoid, and gastrointestinal pheochromocyto-
ma). On occasion, the primary lesion of the tumor releasing ACTH
cannot be detected. In our case a tumor was detected by means of
CT and was confirmed to be an ACTH-producing tumor on the
basis of the scintigraphic findings. Pathologic diagnosis was lymph
node metastasis of a carcinoid; a primary lesion, however, could
not be identified despite thorough examinations. Aniszewski and
colleagues5 reported that no tumor was detected in 17 (16%) of
106 cases of ectopic ACTH syndrome. They found bronchial
carcinoid to be the most frequent cause of this paraneoplastic
disorder. Several reports have also shown the frequent involve-
ment of regional lymph nodes in cases of atypical carcinoid tumor.
Our patient had mediastinal nodal involvement but no detectable
primary lesion in either the lung or the thymus. After removal,
symptoms associated with Cushing syndrome disappeared, and the
value of the ACTH level returned to normal. Thus, it is suggested
that the lymph nodes removed by means of thoracoscopic surgery
were the major origin of ectopic ACTH in our case. There have
been some reports of Tx N2 M0 lung cancer. Thus, we concluded
that this case was a carcinoid tumor with Tx N2 M0 stage IIIA
disease. However, we could not find any reports of Tx N2 M0
carcinoid tumors. Careful follow-up for detection of a possible
occult primary pulmonary lesion is required.
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Figure 1. A, Chest CT showed an abnormal mass (arrows) in the right upper mediastinum. B, Octoreoscan revealed
a hot spot in the mediastinum. The liver also showed a hot spot after uptake of radiolabeled material.
Figure 2. A, Low-power view of lymph nodes prepared for histologic examination. B, There were many cells of
palisade structure infiltrating among lymphocytes. (Original magnification 10, hematoxylin and eosin.)
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